Notify me when Invenomic Capital Management LP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 141 | $1.91B | +$577M | -$549M | +$28.2M | GPN, XRAY, EGO, VTRS, ACHC | 13F-HR | 11/14/2025, 04:00 PM |
| Q2 2025 | 148 | $1.76B | +$467M | -$750M | -$282M | GPN, XRAY, VTRS, EGO, RNG | 13F-HR | 8/14/2025, 04:00 PM |
| Q1 2025 | 168 | $1.97B | +$845M | -$514M | +$331M | VTRS, AKAM, GPN, TFX, LYFT | 13F-HR | 5/15/2025, 04:00 PM |
| Q4 2024 | 153 | $1.78B | +$503M | -$529M | -$25.8M | GPN, XRAY, ES, VTRS, TAP | 13F-HR | 2/14/2025, 04:00 PM |
| Q3 2024 | 141 | $1.81B | +$449M | -$685M | -$236M | GPN, MTB, LYFT, VTRS, ZM | 13F-HR | 11/14/2024, 04:00 PM |
| Q2 2024 | 157 | $1.92B | +$670M | -$486M | +$184M | ES, CHRD, GPN, T, VTRS | 13F-HR | 8/14/2024, 04:00 PM |
| Q1 2024 | 145 | $1.88B | +$620M | -$631M | -$11.1M | CHRD, CLVT, VTRS, SSNC, T | 13F-HR | 5/15/2024, 04:00 PM |
| Q4 2023 | 166 | $1.88B | +$582M | -$1.36B | -$777M | VTRS, SSNC, ILMN, CLVT, CHRD | 13F-HR | 2/14/2024, 12:00 PM |
| Q3 2023 | 145 | $2.38B | +$970M | -$309M | +$661M | SPY, AAPL, VTRS, C, BMY | 13F-HR | 11/14/2023, 02:38 PM |
| Q2 2023 | 132 | $1.79B | +$402M | -$418M | -$16.3M | CLVT, FLT, VTRS, WEX, SSNC | 13F-HR | 8/14/2023, 04:58 PM |
| Q1 2023 | 138 | $1.76B | +$712M | -$462M | +$250M | FLT, CLVT, SSNC, DBX, CMCSA | 13F-HR | 5/15/2023, 10:06 AM |
| Q4 2022 | 137 | $1.38B | +$516M | -$388M | +$128M | APP, FTDR, IPGP, LYFT, EBAY | 13F-HR | 2/14/2023, 11:12 AM |
| Q3 2022 | 145 | $1.16B | +$467M | -$408M | +$59.5M | DBX, UHS, T, EBAY, CMCSA | 13F-HR | 11/14/2022, 04:09 PM |
| Q2 2022 | 143 | $1.15B | +$558M | -$151M | +$407M | UHS, T, CMCSA, DBX, WBD | 13F-HR | 8/15/2022, 01:50 PM |
| Q1 2022 | 147 | $605M | +$367M | -$80.4M | +$287M | T, DBX, ATGE, POSH, HRB | 13F-HR | 5/16/2022, 12:10 PM |
| Q4 2021 | 138 | $426M | +$219M | -$75.4M | +$144M | LRN, HRB, T, BPOP, RGA | 13F-HR | 2/11/2022, 05:09 PM |
| Q3 2021 | 115 | $281M | +$103M | -$41M | +$61.8M | HRB, LRN, GTS, BCEI, KOP | 13F-HR | 11/15/2021, 05:31 PM |
| Q2 2021 | 114 | $225M | +$75.5M | -$67.8M | +$7.69M | LRN, HRB, BCEI, KGC, TECK | 13F-HR | 8/16/2021, 02:53 PM |
| Q1 2021 | 109 | $207M | +$79M | -$70.4M | +$8.59M | HRB, TZOO, BCEI, KGC, MG | 13F-HR | 5/13/2021, 02:10 PM |
| Q4 2020 | 128 | $167M | +$58.8M | -$75.5M | -$16.7M | HRB, KGC, LRN, HSII, CHL | 13F-HR | 2/17/2021, 08:03 AM |
| Q3 2020 | 130 | $139M | +$53.5M | -$57.5M | -$4.03M | HRB, HSII, SKT, DHIL, UGI | 13F-HR | 11/13/2020, 10:59 AM |
| Q2 2020 | 147 | $135M | +$36.2M | -$49.1M | -$12.9M | LRN, UGI, DHIL, MIK, NOMD | 13F-HR | 8/13/2020, 03:54 PM |
| Q1 2020 | 145 | $119M | +$49.1M | -$102M | -$53M | LRN, AAWW, IDCC, RMR, UGI | 13F-HR | 5/13/2020, 04:47 PM |
| Q4 2019 | 113 | $247M | $0 | $0 | BHC, JBLU, AAWW, RJF, SAVE | 13F-HR | 2/14/2020, 09:47 AM |